EyePoint Pharmaceuticals Mergers and Acquisitions Summary

Medical ProductsCompany

EyePoint Pharmaceuticals has acquired 1 company, including 1 in the last 5 years.

EyePoint Pharmaceuticals’ largest acquisition to date was in 2018, when it acquired Icon Bioscience for $61M. EyePoint Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to EyePoint Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 3

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals, Inc.

480 Pleasant Street, Suite B300,
Watertown, Massachusetts 02472
United States,
(617) 926-5000

EyePoint Pharmaceuticals is a provider of miniaturized, sustained-release drug delivery products and is continuing the evolution of these systems. EyePoint Pharmaceuticals was founded in 1987 and is based in Watertown, Massachusetts.

M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (0.2/yr) # - 1 - - - - 1
vol $61M $61M
Sell (0.0/yr) # - - - - - - 0

Most Recent M&A

Company Date Value Type
Icon Bioscience, Inc. 2018-03-28 61M USD Add-on Acquisition
Newark, California · www.iconbioscience.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 61M (100%) - -
Total 1 $61M - -

By Geo

State/Country Buy Value Sell Value
United States 1 61M - -
  California 1 61M - -
Total 1 $61M - -

Top M&A Advisors

Financial Deals
Torreya Partners LLC
MTS Health Partners LP
Legal Deals
Hogan Lovells

Deal Values

buy # Total
< $100M 1 $61M
Largest Icon Bioscience, Inc.
$61M (2018-03-28)

 Subscribe to unlock this and 180,003
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.3K Private Equity Firms
  • 170K M&A Transactions
  • 176K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 63K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.